Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;1:1335–1347.

Article  Google Scholar 

Golabi P, Paik JM, Kumar A et al. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States. Metabolism. 2023;146:155642.

Article  CAS  PubMed  Google Scholar 

Ajmera V, Cepin S, Tesfai K et al. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023;78:471–478.

Article  CAS  PubMed  Google Scholar 

Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679–689.

Article  CAS  PubMed  Google Scholar 

En Li Cho E, Ang CZ, Quek J et al. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis. Gut. 2023;72:2138–2148.

Article  PubMed  Google Scholar 

Quek J, Chan KE, Wong ZY et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8:20–30.

Article  CAS  PubMed  Google Scholar 

Kanwal F, Shubrook JH, Adams LA et al. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease. Gastroenterology. 2021;161:1657–1669.

Article  CAS  PubMed  Google Scholar 

Rinella ME, Neuschwander-Tetri BA, Siddiqui MS et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;1:1797–1835.

Article  Google Scholar 

Cusi K, Isaacs S, Barb D et al. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings: co-sponsored by the American Association for the Study of Liver Diseases (AASLD). Endocr Pract. 2022;28:528–562.

Article  PubMed  Google Scholar 

Tacke F, Horn P, Wai-Sun Wong V, et al. EASL–EASD–EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024.

Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-alcoholic fatty liver disease: a critical appraisal. J Hepatol. 2013;58:1007–1019.

Article  PubMed  Google Scholar 

Springer F, Machann J, Claussen CD, Schick F, Schwenzer NF. Liver fat content determined by magnetic resonance imaging and spectroscopy. World J Gastroenterol. 2010;7:1560–1566.

Article  Google Scholar 

Yokoo T, Serai SD, Pirasteh A et al. Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology. 2018;286:486–498.

Article  PubMed  Google Scholar 

Caussy C, Johansson L. Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Endocrinol Diabetes Metab. 2020;3:e00134.

Article  PubMed  PubMed Central  Google Scholar 

Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1264–1281.e4.

Article  PubMed  Google Scholar 

Sasso M, Beaugrand M, de Ledinghen V et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010;36:1825–1835.

Article  PubMed  Google Scholar 

de Lédinghen V, Wong GL, Vergniol J et al. Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2016;31:848–855.

Article  PubMed  Google Scholar 

Eddowes PJ, Sasso M, Allison M et al. Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1717–1730.

Article  PubMed  Google Scholar 

Karlas T, Petroff D, Sasso M et al. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol. 2017;66:1022–1030.

Article  PubMed  Google Scholar 

Petroff D, Blank V, Newsome PN et al. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:185–198.

Article  PubMed  Google Scholar 

Bossuyt PM, Reitsma JB, Bruns DE et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Bmj. 2015;28:h5527.

Article  Google Scholar 

Qadri S, Vartiainen E, Lahelma M et al. Marked difference in liver fat measured by histology vs magnetic resonance-proton density fat fraction: a meta-analysis. JHEP Rep. 2024;6:100928.

Article  PubMed  Google Scholar 

Caussy C, Reeder SB, Sirlin CB, Loomba R. Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology. 2018;68:763–772.

Article  PubMed  Google Scholar 

Caussy C, Alquiraish MH, Nguyen P et al. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018;67:1348–1359.

Article  CAS  PubMed  Google Scholar 

Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36.

Article  CAS  PubMed  Google Scholar 

Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesthesia Analgesia. 2018;126.

Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32–35.

Article  CAS  PubMed  Google Scholar 

Cohen JF, Korevaar DA, Altman DG et al. STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016;14:e012799.

Article  Google Scholar 

Semmler G, Wöran K, Scheiner B et al. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis. United Eur Gastroenterol J. 2020;8:321–331.

Article  CAS  Google Scholar 

Jung J, Han A, Madamba E et al. Direct comparison of quantitative US versus controlled attenuation parameter for liver fat assessment using MRI proton density fat fraction as the reference standard in patients suspected of having NAFLD. Radiology. 2022;304:75–82.

Article  PubMed  Google Scholar 

Ferraioli G, Maiocchi L, Raciti MV et al. Detection of liver steatosis with a novel ultrasound-based technique: a pilot study using MRI-derived proton density fat fraction as the gold standard. Clin Transl Gastroenterol. 2019;10:e00081.

Article  PubMed  PubMed Central  Google Scholar 

Siddiqui MS, Vuppalanchi R, Van Natta ML et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17:156–63.e2.

Article  PubMed  Google Scholar 

Cao YT, Xiang LL, Qi F, Zhang YJ, Chen Y, Zhou XQ. Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis. EClinicalMedicine. 2022;51:101547.

Article  PubMed  PubMed Central  Google Scholar 

Sirli R, Sporea I. Controlled attenuation parameter for quantification of steatosis: which cut-offs to use? Can J Gastroenterol Hepatol. 2021;2021:6662760.

Article  PubMed  PubMed Central  Google Scholar 

Wong VW, Petta S, Hiriart JB et al. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. J Hepatol. 2017;67:577–584.

Article  PubMed  Google Scholar 

Kuchay MS, Choudhary NS, Sharma D et al. Diagnostic accuracy and optimal cut-off of controlled attenuation parameter for the detection of hepatic steatosis in Indian population. J Clin Exp Hepatol. 2022;12:893–898.

Article